SUMICHEM - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 4.2
Show all parameters (20 more)
🧾 Trade Setup
Entry Price: 455 ₹. Target Exit Level 1: 480 ₹ (based on immediate momentum), Target Exit Level 2: 505 ₹ (upon confirmation of sustained bullishness). This represents a multi-day swing trade with clear profit targets based on near-term price action and dividend support. The elevated valuation necessitates careful monitoring, but the recent earnings growth and positive news warrant an aggressive entry position given the potential for a strong short-term reaction.
✅ Positive
The recent PAT growth of 9.30% quarter-on-quarter, alongside the approved ₹1.30 dividend, provides a strong near-term catalyst for positive momentum. Furthermore, the RSI at 30.0 suggests the stock is currently undervalued relative to its historical momentum and reflects potential buying opportunities.
⚠️ Limitation
Despite the robust earnings growth, the Stock P/E of 40.1 remains elevated compared to the Industry PE of 20.4, indicating significant premium valuation. This could expose the position to a correction if broader market sentiment shifts or if expectations aren’t fully priced in. The Debt to equity is minimal but still warrants monitoring for potential changes.
📉 Company Negative News
Recent news indicates a board reshuffle and a fixed July 17th record date for dividend payment – this represents standard corporate actions, not necessarily negative but highlights ongoing governance processes.
📈 Company Positive News
Sumitomo Chemical India approves ₹1.30 dividend - scanx.trade confirms the distribution of profits to shareholders, which can attract income-seeking investors and potentially drive stock price appreciation.
🏭 Industry
The chemicals sector is currently experiencing moderate growth driven by rising demand in end-user industries like paints, coatings, and adhesives. However, industry PE ratios remain relatively conservative reflecting a mature business environment. There’s ongoing competition and regulatory scrutiny impacting margins.